Telatinib
- Generic Name
- Telatinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H16ClN5O3
- CAS Number
- 332012-40-5
- Unique Ingredient Identifier
- 18P7197Q7J
- Background
Telatinib is under investigation in clinical trial NCT03817411 (Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath